In addition to its stimulatory effect on cell mobility, invasion, and metastasis, which is mainly driven through EMT induction, TG2 can also induce chemoresistance by acting on the structure and stability of the ECM by crosslinking fibronectin and enabling ECM to protect cancer cells from exposure to chemotherapy [178]. Here, TGM2 is linked to cancer.